Table 1.

Bacterial Strains Used in This Study

Strain	Description	Reference or Source
P. aeruginosa
PAO1	Wild-type strain, LPS smooth, non–cytotoxic, serogroup O2/O5, subtype epitopes O2a, O2d	M. Vasila
PAO1ΔaroA	aroA deletion mutant of PAO1, LPS smooth, serogroup O2/O5, subtype epitopes O2a, O2d	[10]
170003	Wild-type strain, LPS smooth, non–cytotoxic, serogroup O2/O5, subtype epitopes O2a, O2b	[40]
IT7	Wild-type strain, LPS smooth, non–cytotoxic, serogroup O2/O5, subtype epitope O2a	[40]
IT4	Clinical isolate (bacteremia), LPS smooth, serogroup O1	[41]
6294	Clinical isolate (corneal infection), LPS smooth, noncytotoxic, serogroup O6	BPEIb and [41, 42]
E. coli HB101	supE44, hsdS20(r-Bm-B), recA13, ara-14, proA2 lacY1, galK2, rpsL20, xyl-5, mtl-1	[43]

Abbreviations: E. coli, Escherichia coli; LPS, lipopolysaccharide; P. aeruginosa, Pseudomonas aeruginosa.

^a M. Vasil, University of Colorado Health Sciences Center, Aurora, CO.

^b Bascom-Palmer Eye Institute, Miami, FL.